Literature DB >> 10326587

Trilateral retinoblastoma with an RB1 deletion inherited from a carrier mother: a case report.

P Amare1, J Jose, P Chitalkar, P Kurkure, S Pai, C Nair, S Advani.   

Abstract

A presentation of intracranial tumor in bilateral and unilateral retinoblastoma with or without family history is termed as trilateral retinoblastoma (TRB). It always occurs either as a pineal tumor or supra/parasellar tumor, which differ in presentation and prognosis. We report here the first case of TRB with transmission of retinoblastoma gene (RB1) deletion from an unaffected mother (a carrier), presenting as concurrent intracranial neoplasm with bilateral retinoblastoma. The presence of RB1 mutation in both child and mother could be responsible for development of intracranial neoplasm which occurred simultaneously with bilateral RB in our patient. Our patient, who had a suprasellar mass, received radiation and intrathecal chemotherapy, and died 6 months after diagnosis. The occurrence of intracranial tumor in an asymptomatic stage can be avoided by routine computed tomography (CT) and magnetic resonance imaging (MRI) scan, and improved survival can be achieved by aggressive multimodality therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10326587     DOI: 10.1016/s0165-4608(98)00220-9

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Trilateral retinoblastoma: A systematic review of 211 cases.

Authors:  Ryuya Yamanaka; Azusa Hayano; Yasuo Takashima
Journal:  Neurosurg Rev       Date:  2017-08-16       Impact factor: 3.042

2.  Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma.

Authors:  Ting Gui; Hui Zheng; Ming Liu; Zhengrong Xia; Xunda Ji; Qiufeng Yin; Dengbin Wang; Yuhua Li; Shuxian Chen
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  Germline and somatic mutations in the pathology of pineal cyst: A whole-exome sequencing study of 93 individuals.

Authors:  Yuanqing Yan; Rebecca Martinez; Maria N Rasheed; Joshua Cahal; Zhen Xu; Yanning Rui; Krista J Qualmann; John P Hagan; Dong H Kim
Journal:  Mol Genet Genomic Med       Date:  2021-05-04       Impact factor: 2.183

4.  Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma.

Authors:  Simona Grotta; Gemma D'Elia; Rossana Scavelli; Silvia Genovese; Cecilia Surace; Pietro Sirleto; Raffaele Cozza; Antonino Romanzo; Maria Antonietta De Ioris; Paola Valente; Anna Cristina Tomaiuolo; Francesca Romana Lepri; Tiziana Franchin; Laura Ciocca; Serena Russo; Franco Locatelli; Adriano Angioni
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.